Answers are grounded in this paper and cite their sources.
The identified 4-biomarker panel could provide diagnostic aid to the existing imaging modalities for AIS due to LVO, and the prognostic value of IGF2, LYVE1, and THBS1 was proved in predicting functional outcomes related to collateral status. Trial registration ClinicalTrials.gov NCT03122002. Retrospectively registered April 20, 2017. URL of trial registry record: https://www.clinicaltrials.gov/ct2/show/NCT03122002?term=NCT+03122002&rank=1.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: